Weiss Multi-Strategy Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,927
| Closed | -$1.31M | – | 789 |
|
|
2022
Q1 | $1.31M | Sell |
15,927
-4,109
| -21% | -$338K | 0.03% | 445 |
|
|
2021
Q4 | $2.94M | Buy |
20,036
+10,036
| +100% | +$1.47M | 0.07% | 316 |
|
|
2021
Q3 | $1.77M | Sell |
10,000
-1,114
| -10% | -$197K | 0.04% | 417 |
|
|
2021
Q2 | $1.8M | Buy |
+11,114
| New | +$1.8M | 0.04% | 399 |
|
|
2021
Q1 | – | Sell |
-929
| Closed | -$204K | – | 815 |
|
|
2020
Q4 | $204K | Sell |
929
-2,076
| -69% | -$456K | ﹤0.01% | 605 |
|
|
2020
Q3 | $499K | Sell |
3,005
-9,288
| -76% | -$1.54M | 0.01% | 458 |
|
|
2020
Q2 | $1.4M | Sell |
12,293
-11,291
| -48% | -$1.29M | 0.04% | 354 |
|
|
2020
Q1 | $1.81M | Buy |
23,584
+10,584
| +81% | +$814K | 0.07% | 249 |
|
|
2019
Q4 | $1.68M | Buy |
+13,000
| New | +$1.68M | 0.03% | 375 |
|